Pharmaceuticals, Biotechnology and Life Sciences
Novartis has announced the publication of the CLAIM study in the Lancet Respiratory Medicine, which demonstrated that treatment once-daily Ultibro…
Vertex Pharmaceuticals wants to submit a New Drug Application in the USA, so it will soon give the final test…
BASF Corporation is introducing Hepaxa, a product that can help tens of millions of patients manage Non-Alcoholic Fatty Liver Disease…
STA Pharmaceutical, a WuXi AppTec group company has entered into a deal with Regulus Therapeutics, an oligonucleotide synthesis collaboration agreement…
Celgene expects the transaction for Juno Therapeutics shares, to close in the first quarter of 2018. The company has said Wednesday…
Tetraphase Pharmaceuticals which creates antibiotics to treat life-threatening multidrug-resistant (MDR) infections, has gotten a licensing agreement with Everest Medicines Limited,…
CARB-X has announced its 2018 rounds of funding to support research into the development of antibiotics, vaccines, diagnostics, devices and…
Ritter Pharmaceuticals will seek to do make sure its first pivotal Phase 3 clinical trial of RP-G28 for lactose intolerance…
Hikma Pharmaceuticals has appointed Sigurdur (Siggi) Olafsson as Chief Executive Officer (CEO), who will also join Hikma’s Board of Directors…
Horizon Discovery’s CEO Darrin M. Disley has decided to step down to “pursue other business interests”. To replace him temporarily,…